Billionaire Profile
Frank Laukien
Global Rank
#2665

Image: Conrad Erb | CC BY-SA 3.0 | via Wikimedia Commons

Frank Laukien

CEO, Scientific equipment
UNITED STATES
Real-Time Net Worth
$1.486B
Estimated based on Scientific equipment stock value as of April 20, 2026
0% (24h)
Age
66
Source
Scientific equipment
Industry
Manufacturing
Citizenship
UNITED STATES

Biography

Frank Laukien is the Chairman, President, and CEO of Bruker Corporation, a leading manufacturer of scientific instruments. With a net worth of $1.5 billion, he is the largest shareholder of the company. Laukien's career has been centered on advancing scientific innovation and expanding Bruker's global presence in the scientific equipment industry. He holds a Ph.D. in chemical physics from Harvard University and a Bachelor of Science degree in physics from MIT, where he studied economics and accounting. His leadership has transformed Bruker into a major player in life sciences, materials research, and biopharma applications.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Frank H. Laukien was born in 1960 in Stuttgart, Germany. He is the son of Günther Laukien, the founder of Bruker Corporation. His mother was a high school teacher. Laukien's upbringing in a family involved in the scientific instrument industry shaped his early interest in physics and technology.

Rise to Success

Laukien earned a Bachelor of Science degree in physics from the Massachusetts Institute of Technology (MIT) and a Ph.D. in chemical physics from Harvard University. He started working at Bruker during his summers in college. After completing his doctorate, he joined Bruker full-time. He was appointed Chairman, President, and CEO of Bruker Corporation in February 1991.

Key Business Strategies

Under Laukien's leadership, Bruker went public on NASDAQ in 2000 and expanded through strategic acquisitions and R&D investments. Laukien owns approximately 26% of the publicly traded firm. The company focuses on advanced technologies like mass spectrometry, X-ray diffraction, and magnetic resonance. Bruker's revenue for 2025 was $3.44 billion.

Philanthropy

Laukien has made significant contributions to scientific research initiatives, including supporting an MIT glycobiology program. He has also served as a visiting scholar at Harvard University's Origins of Life Initiative and supports cancer research.

Career Milestones

1984

Graduated from MIT

Earned a Bachelor of Science degree in physics.

1988

Received a PhD from Harvard

Completed a doctorate in chemical physics.

1991

CEO of Bruker Corporation

Appointed Chairman, President, and Chief Executive Officer of Bruker Corporation.

2000

Bruker Goes Public

Led Bruker Corporation to go public on NASDAQ.

2024

Glycobiology Program

Announced support for an MIT glycobiology program

Philanthropy & Social Impact

Research

MIT Glycobiology Program

$XB

Funding efforts to advance research in this field through collaborations across the institute.